Home > Analytics > CADILA HEALTHCARE

CADILA HEALTHCARE
Intrinsic Value | Fundamental Analysis

BOM : 532321     NSE : CADILAHC    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Dec 02,2022
Price(EOD): ₹ 415.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 42,061.97 Cr
Value of ₹ 1 Lac invested in CADILA HEALTHCARE
on Dec 04,2017 (price: ₹ 424.10)

₹ 1 L

₹ 0.98 L

1W : 4.1% 1M : -4.8% 1Y : -11.6%
COMMUNITY POLL
for CADILA HEALTHCARE
Please provide your vote to see the results
CADILA HEALTHCARE is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
CADILA HEALTHCARE 4.1% -4.8% -11.6%
SUN PHARMACEUTICAL INDUSTRIES 0.6% -1.1% 38.8%
DIVIS LABORATORIES 0.2% -10.6% -30.7%
DR REDDYS LABORATORIES 2.5% -1% -5.8%
CIPLA 1% -4% 15.8%
GLAND PHARMA -1.3% -8.4% -51.1%
PIRAMAL ENTERPRISES 4.8% 2.6% -64.3%
TORRENT PHARMACEUTICALS -0.9% -4.3% 7.9%
ALKEM LABORATORIES 1.2% -6% -12.9%

FUNDAMENTAL ANALYSIS OF CADILA HEALTHCARE

 
Fundamentals Score
[ Q(TTM): Sep2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 CADILAHC is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF CADILA HEALTHCARE

 
Valuation Score
[As on : Dec 02,2022 ]

Ratio Consolidated
P/E
P/B
P/S
20.82
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 2,020.40 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

2.47
P/B Calculated based on Book Value of Rs 16,999.60 Cr
[Latest Year - Mar2022 - Consolidated Results ]

2.67
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 15,726.20 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 16% undervalued companies ! Discover More →

FAIR VALUE OF CADILA HEALTHCARE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-9%
-13%
-11%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF CADILA HEALTHCARE



CADILA HEALTHCARE vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF CADILA HEALTHCARE

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.2
0.31
0.33
0.28
0.25
0.35
0.77
0.46
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF CADILA HEALTHCARE

Pledged Promoter Shares
0 %
As on : Sep2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF CADILA HEALTHCARE

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
1.52%
-2.12%
-5.61%
-10.1%
9.97%
-9.36%
-25.09%
-29.98%
QtrlyTrend
-4
Latest Qtr: Sep2022
Quarterly Result Analysis →


CADILA HEALTHCARE related INDICES

BSE Indices1W1M1Y
S&P BSE DIVIDEND STABILITY 1.6% 3.1% 9.4%
S&P BSE ALLCAP 1.6% 2.7% 9.4%
S&P BSE 500 1.5% 2.6% 9.2%
S&P BSE 250 LARGEMIDCAP 1.4% 2.5% 9.3%
S&P BSE 200 1.4% 2.5% 9.6%
NSE Indices1W1M1Y
NIFTY FREE MIDCAP 100 3.1% 2.7% 10.3%
NIFTY MIDCAP150 2.9% 2.7% 10.3%
NIFTY MID SMALL400 2.7% 3.1% 9.2%
NIFTY MIDCAP 50 2.7% 2.6% 10%
NIFTY LARGE MIDCAP 250 2% 2.7% 9.7%

You may also like the below Video Courses


FAQ about CADILA HEALTHCARE


Is CADILA HEALTHCARE good for long term investment?

As on Dec 02,2022, the Fundamentals of CADILA HEALTHCARE look Strong and hence it may be good for long term investment! See Financial Performance of CADILA HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is CADILA HEALTHCARE UnderValued or OverValued?

As on Dec 02,2022, CADILA HEALTHCARE is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of CADILA HEALTHCARE ?

As on Dec 02,2022, the Intrinsic Value of CADILA HEALTHCARE is Rs. 468.00 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 459.06
Fair Value [Median EV / Sales Model] : Rs. 477.72
Fair Value [Median Price / Sales Model] : Rs. 468.00
Estimated Median Fair Value of CADILA HEALTHCARE : Rs. 468.00

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is CADILA HEALTHCARE trading at a Premium or Discount?

As on Dec 02,2022, CADILA HEALTHCARE is trading at a Discount of -11% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].